AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36107843 — intervention group
Group type: COMPARATOR
Intervention: Vehicle nasal spray BID
Number of subjects: 182
Study 33251022 — intervention group
Group type: EXPERIMENTAL
Intervention: VHM + ART
Number of subjects: 15
Study 33251022 — intervention group
Group type: COMPARATOR
Intervention: ART only
Number of subjects: 15
Study 33251022 — intervention group
Group type: EXPERIMENTAL
Intervention: VHM + ART and ART only
Number of subjects: 15
Study 33792961 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-assisted hyaluronic acid (HA) delivery with ablative fractional carbon dioxide laser (AFXL)
Number of subjects: 20
Study 33792961 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline
Number of subjects: 20
Study 32204612 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 135
Study 32204612 — intervention group
Group type: EXPERIMENTAL
Intervention: Core stability training
Number of subjects: 135
Study 32204612 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 135
Study 32204612 — intervention group
Group type: EXPERIMENTAL
Intervention: Core stability training vs. Acupuncture
Number of subjects: 135
Study 32204612 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional capacity measures
Number of subjects: 135
Study 34238436 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 1280
Study 34238436 — intervention group
Group type: COMPARATOR
Intervention: Drug therapy
Number of subjects: 1280
Study 33119078 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy
Number of subjects: 26
Study 33119078 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting
Number of subjects: 26
Study 33180994 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer Intervention (PI)
Number of subjects: 400
Study 33180994 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 400
Study 33180994 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported depression symptoms
Number of subjects: 400
Study 33180994 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity level
Number of subjects: 400
Study 33180994 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatric symptoms
Number of subjects: 400
Study 33180994 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-related quality of life
Number of subjects: 400
Study 33180994 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 400
Study 33180994 — intervention group
Group type: EXPERIMENTAL
Intervention: Components of the Motivation Volition Process Model
Number of subjects: 400
Study 32672612 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% Nepafenac
Number of subjects: 152
Study 32672612 — intervention group
Group type: COMPARATOR
Intervention: 1% Prednisolone Acetate
Number of subjects: 152
Study 34635804 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT) treatment once a week for four weeks with 3000 impulses each
Number of subjects: 155
Study 34635804 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment with air-filled microspheres
Number of subjects: 155
Study 34635804 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 155
Study 35217003 — intervention group
Group type: EXPERIMENTAL
Intervention: dupilumab 300 mg every 2 weeks for up to 96 weeks
Number of subjects: 187
Study 35217003 — intervention group
Group type: COMPARATOR
Intervention: placebo in VENTURE followed by dupilumab in TRAVERSE
Number of subjects: 187
Study 35217003 — intervention group
Group type: EXPERIMENTAL
Intervention: dupilumab
Number of subjects: 187
Study 33819216 — intervention group
Group type: EXPERIMENTAL
Intervention: Active isolated stretching (self-assisted) before eccentric exercises
Number of subjects: 60
Study 35387483 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 60 mg BD
Number of subjects: 200
Study 35387483 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 100 mg OD
Number of subjects: 200
Study 33955842 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonfood photography while eating
Number of subjects: 208
Study 33955842 — intervention group
Group type: EXPERIMENTAL
Intervention: Food photography while eating
Number of subjects: 208
Study 33955842 — intervention group
Group type: COMPARATOR
Intervention: No phone use
Number of subjects: 208
Study 32879783 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosulpiride (25 mg orally TID for 7 days)
Number of subjects: 35
Study 32879783 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose pill, orally TID for 7 days)
Number of subjects: 35
Study 35902936 — intervention group
Group type: EXPERIMENTAL
Intervention: Propolis mouthwash (2.5%)
Number of subjects: 17
Study 35902936 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthwash (normal saline)
Number of subjects: 17
Study 33756421 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin with pegylated liposomal doxorubicin (CD)
Number of subjects: 976
Study 33756421 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin with paclitaxel (CP)
Number of subjects: 976
Study 33756421 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 976
Study 36396451 — intervention group
Group type: EXPERIMENTAL
Intervention: Atogepant 10 mg
Number of subjects: 910
Study 36396451 — intervention group
Group type: EXPERIMENTAL
Intervention: Atogepant 30 mg
Number of subjects: 910
Study 36396451 — intervention group
Group type: EXPERIMENTAL
Intervention: Atogepant 60 mg
Number of subjects: 910
Study 36396451 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 910
Study 33518350 — intervention group
Group type: EXPERIMENTAL
Intervention: Free range (FR) housing environment
Number of subjects: 12
Study 33518350 — intervention group
Group type: EXPERIMENTAL
Intervention: Hy-Line W-36 strain
Number of subjects: 12
Study 33518350 — intervention group
Group type: EXPERIMENTAL
Intervention: Hy-Line Brown strain
Number of subjects: 12
Study 32512353 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive group-based psychosocial intervention (12 weekly sessions and 3 monthly booster sessions)
Number of subjects: 68
Study 32512353 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 68
Study 36459058 — intervention group
Group type: EXPERIMENTAL
Intervention: Cloth mask
Number of subjects: 40
Study 36459058 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical mask
Number of subjects: 40
Study 36459058 — intervention group
Group type: EXPERIMENTAL
Intervention: FFP2 mask
Number of subjects: 40
Study 36459058 — intervention group
Group type: COMPARATOR
Intervention: No mask (control)
Number of subjects: 40
Study 32970235 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved nutrition in the first 1000 days
Number of subjects: 1027
Study 32970235 — intervention group
Group type: COMPARATOR
Intervention: Other exposure status (less nutritious supplement or improved nutrition at other ages)
Number of subjects: 1027
Study 32970235 — intervention group
Group type: EXPERIMENTAL
Intervention: Other biomarkers
Number of subjects: 1027
Study 35403949 — intervention group
Group type: EXPERIMENTAL
Intervention: IDegLira
Number of subjects: 24
Study 35403949 — intervention group
Group type: COMPARATOR
Intervention: IDegAsp
Number of subjects: 24
Study 33585943 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic balance training
Number of subjects: 22
Study 33585943 — intervention group
Group type: COMPARATOR
Intervention: Conventional balance training
Number of subjects: 22
Study 33305551 — intervention group
Group type: COMPARATOR
Intervention: Resistance Training (RT)
Number of subjects: 48
Study 33305551 — intervention group
Group type: COMPARATOR
Intervention: Dynamic Training (DT)
Number of subjects: 48
Study 32090585 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional advice and nutritional supplementation for 12 weeks
Number of subjects: 76
Study 32090585 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 76
Study 36242868 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency cervical cerclage (ECC)
Number of subjects: 34
Study 36242868 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 34
Study 32495016 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic radical resection (LRR)
Number of subjects: 168
Study 32495016 — intervention group
Group type: COMPARATOR
Intervention: Open abdominal radical hysterectomy
Number of subjects: 168
Study 36261917 — intervention group
Group type: EXPERIMENTAL
Intervention: STUDYCoach online intervention (used over three consecutive weeks)
Number of subjects: 209
Study 36261917 — intervention group
Group type: EXPERIMENTAL
Intervention: STUDYCoach online intervention
Number of subjects: 209
Study 36261917 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 209
Study 33619316 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically higher education level
Number of subjects: 0
Study 33619316 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher education level adjusted for intelligence
Number of subjects: 0
Study 33619316 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher education level
Number of subjects: 0
Study 32102646 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate diluted in 5% dextrose (D5W)
Number of subjects: 60
Study 32102646 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants using a clue
Number of subjects: 60
Study 32102646 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants not using a clue
Number of subjects: 60
Study 36384493 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard medical therapy combined with NBP treatment (NBP 200 mg, three times per day for 24 weeks)
Number of subjects: 0
Study 36384493 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy
Number of subjects: 0
Study 32090511 — intervention group
Group type: EXPERIMENTAL
Intervention: HTGW+ individuals
Number of subjects: 6874
Study 32090511 — intervention group
Group type: COMPARATOR
Intervention: HTGW- individuals
Number of subjects: 6874
Study 35199250 — intervention group
Group type: EXPERIMENTAL
Intervention: Indocyanine green injection with the da Vinci Xi‐equipped Firefly system
Number of subjects: 55
Study 34322967 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec U100
Number of subjects: 498
Study 34322967 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine U100
Number of subjects: 498
Study 35123236 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Rapid Infuser
Number of subjects: 240
Study 35123236 — intervention group
Group type: EXPERIMENTAL
Intervention: Push-pull with 60 mL syringe
Number of subjects: 240
Study 35123236 — intervention group
Group type: EXPERIMENTAL
Intervention: Push-pull with 10 mL syringe
Number of subjects: 240
Study 35123236 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand pump with pressure bag
Number of subjects: 240
Study 35123236 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand pump without pressure bag
Number of subjects: 240
Study 35123236 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure bag
Number of subjects: 240
Study 35123236 — intervention group
Group type: EXPERIMENTAL
Intervention: Gravity
Number of subjects: 240
Study 34285664 — intervention group
Group type: EXPERIMENTAL
Intervention: Micromedex
Number of subjects: 162
Study 34285664 — intervention group
Group type: EXPERIMENTAL
Intervention: Micromedex with Watson
Number of subjects: 162
Study 34285664 — intervention group
Group type: COMPARATOR
Intervention: Google
Number of subjects: 162
Study 34637559 — intervention group
Group type: EXPERIMENTAL
Intervention: BFR resistance training
Number of subjects: 0
Study 34637559 — intervention group
Group type: COMPARATOR
Intervention: Control (non-exercising patients)
Number of subjects: 0
Study 33601395 — intervention group
Group type: EXPERIMENTAL
Intervention: MCS (conventional stockings)
Number of subjects: 33
Study 33601395 — intervention group
Group type: EXPERIMENTAL
Intervention: MCS-SkC (compression stockings with integrated care emulsion)
Number of subjects: 33
Study 36107412 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Intravenous Anesthesia (TIVA)
Number of subjects: 78
Study 36107412 — intervention group
Group type: COMPARATOR
Intervention: Inhalational Anesthesia (INH)
Number of subjects: 78
Study 34324724 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA-PDT + IPL
Number of subjects: 20
Study 34324724 — intervention group
Group type: COMPARATOR
Intervention: ALA-PDT only
Number of subjects: 20
Study 33664158 — intervention group
Group type: EXPERIMENTAL
Intervention: Music Attention Control Training (MACT)
Number of subjects: 0
Study 33664158 — intervention group
Group type: COMPARATOR
Intervention: Attention Process Training (APT)
Number of subjects: 0
Study 34240627 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS for 6 months
Number of subjects: 100
Study 34240627 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS for 6 months
Number of subjects: 100
Study 33268967 — intervention group
Group type: EXPERIMENTAL
Intervention: WNJT (n = 147)
Number of subjects: 291
Study 33268967 — intervention group
Group type: COMPARATOR
Intervention: Nasal cannula (n = 144)
Number of subjects: 291
Study 36052536 — intervention group
Group type: EXPERIMENTAL
Intervention: Enfortumab vedotin (EV) 1.25 mg/kg on Days 1, 8, and 15 for 28-day cycles
Number of subjects: 86
Study 36052536 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapy (SC; docetaxel or paclitaxel) on Day 1 of each 21-day cycle
Number of subjects: 86
Study 34265066 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 15
Study 34265066 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 33033049 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy intervertebral discs (Pfirrmann grade ≤2)
Number of subjects: 101
Study 33033049 — intervention group
Group type: EXPERIMENTAL
Intervention: Degenerated intervertebral discs (Pfirrmann grade ≥3)
Number of subjects: 101
Study 33033049 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrasubject variability for healthy intervertebral discs
Number of subjects: 101
Study 33033049 — intervention group
Group type: COMPARATOR
Intervention: All segment-matched healthy discs as references
Number of subjects: 101
Study 33104373 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal resources training intervention
Number of subjects: 102
Study 33104373 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 102
Study 34087466 — intervention group
Group type: EXPERIMENTAL
Intervention: ICG‐aPDT
Number of subjects: 50
Study 33006966 — intervention group
Group type: EXPERIMENTAL
Intervention: High perceived criticism from romantic partners
Number of subjects: 49
Study 33006966 — intervention group
Group type: EXPERIMENTAL
Intervention: High perceived criticism from parents
Number of subjects: 49
Study 33006966 — intervention group
Group type: EXPERIMENTAL
Intervention: High perceived criticism from friends
Number of subjects: 49
Study 33006966 — intervention group
Group type: COMPARATOR
Intervention: Low perceived criticism
Number of subjects: 49
Study 34688923 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 98
Study 34688923 — intervention group
Group type: COMPARATOR
Intervention: Present-centered group therapy (control)
Number of subjects: 98
Study 32538006 — intervention group
Group type: EXPERIMENTAL
Intervention: Nape cluster acupuncture combined with swallowing function training
Number of subjects: 60
Study 32538006 — intervention group
Group type: COMPARATOR
Intervention: Swallowing function training (control group)
Number of subjects: 60
Study 34767474 — intervention group
Group type: EXPERIMENTAL
Intervention: Oncology nurse-led primary palliative care intervention (CONNECT)
Number of subjects: 457
Study 34767474 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 457
Study 33064207 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel herbal toothpaste containing clove, aloe vera, amla, neem, tulsi, honey, 0.96% zinc, and 0.76% SMFP (1000 ppm F) in a calcium carbonate base.
Number of subjects: 70
Study 33064207 — intervention group
Group type: COMPARATOR
Intervention: Fluoride toothpaste containing 0.76% SMFP (1000 ppm F) in a calcium carbonate base (Colgate Cavity Protection).
Number of subjects: 70
Study 33064207 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel herbal toothpaste
Number of subjects: 70
Study 32320285 — intervention group
Group type: EXPERIMENTAL
Intervention: 45‐kHz frequency at 1 mm
Number of subjects: 40
Study 32320285 — intervention group
Group type: COMPARATOR
Intervention: 1‐MHz frequency at 1 mm
Number of subjects: 40
Study 32320285 — intervention group
Group type: EXPERIMENTAL
Intervention: 45‐kHz frequency at 4 mm
Number of subjects: 40
Study 32320285 — intervention group
Group type: COMPARATOR
Intervention: 1‐MHz frequency at 4 mm
Number of subjects: 40
Study 32320285 — intervention group
Group type: EXPERIMENTAL
Intervention: Both frequencies
Number of subjects: 40
Study 96008295 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN-alpha) at a dose of 5MU daily or 10 MU three times a week for 3 to 6 months
Number of subjects: 0
Study 96008295 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapies including interferon alpha with Ara-AMP, acyclovir, didoxynucleoside or interferon-gamma
Number of subjects: 0
Study 35715644 — intervention group
Group type: EXPERIMENTAL
Intervention: Astodrimer sodium nasal spray (1%)
Number of subjects: 40
Study 35715644 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 33426570 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid gel (HAG)
Number of subjects: 150
Study 33426570 — intervention group
Group type: COMPARATOR
Intervention: Fat
Number of subjects: 150
Study 33408857 — intervention group
Group type: EXPERIMENTAL
Intervention: NPWT with normal saline instillation (NPWTi)
Number of subjects: 48
Study 33408857 — intervention group
Group type: COMPARATOR
Intervention: NPWT
Number of subjects: 48
Study 33248578 — intervention group
Group type: EXPERIMENTAL
Intervention: Protease supplementation (20,000U/kg)
Number of subjects: 576
Study 33248578 — intervention group
Group type: COMPARATOR
Intervention: Low-protein diets (13.5% CP)
Number of subjects: 576
Study 33248578 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction of low-protein diets and protease supplementation
Number of subjects: 576
Study 34352588 — intervention group
Group type: EXPERIMENTAL
Intervention: EP prenylflavonoid extract (740 mg daily)
Number of subjects: 58
Study 34352588 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 32888702 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Exercise Program (PEP) for 12 weeks
Number of subjects: 20
Study 36379585 — intervention group
Group type: EXPERIMENTAL
Intervention: Add-on imeglimin 1000 mg two times per day
Number of subjects: 70
Study 36379585 — intervention group
Group type: COMPARATOR
Intervention: Metformin dose escalation
Number of subjects: 70
Study 33300818 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast formulations
Number of subjects: 24
Study 33300818 — intervention group
Group type: EXPERIMENTAL
Intervention: Processed plasma samples exposed to fluorescent light for 24h
Number of subjects: 24
Study 33300818 — intervention group
Group type: EXPERIMENTAL
Intervention: Unprocessed plasma samples
Number of subjects: 24
Study 33300818 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard calibration curve
Number of subjects: 24
Study 32167260 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganglion cell complex thickness-to-total retinal thickness ratio (G/T ratio)
Number of subjects: 86
Study 32167260 — intervention group
Group type: EXPERIMENTAL
Intervention: Average RNFLT, average GCC, total retinal thickness
Number of subjects: 86
Study 32167260 — intervention group
Group type: COMPARATOR
Intervention: Healthy group
Number of subjects: 86
Study 35417758 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate, High-Protein (LC/HP) diet for 8 weeks
Number of subjects: 19
Study 35417758 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual diet) for 8 weeks
Number of subjects: 19
Study 34047904 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-acupressure
Number of subjects: 0
Study 34047904 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 0
Study 32123969 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu-Dotatate (every 8 weeks, four cycles) plus octreotide long-acting release (LAR)
Number of subjects: 0
Study 32123969 — intervention group
Group type: COMPARATOR
Intervention: octreotide LAR 60 mg
Number of subjects: 0
Study 32123969 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu-Dotatate
Number of subjects: 0
Study 35698187 — intervention group
Group type: EXPERIMENTAL
Intervention: Post Isometric Relaxation
Number of subjects: 60
Study 35698187 — intervention group
Group type: COMPARATOR
Intervention: Myofascial Release Therapy
Number of subjects: 60
Study 35057905 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal lactic acid gel (5 ml once daily for 7 days)
Number of subjects: 518
Study 35057905 — intervention group
Group type: COMPARATOR
Intervention: Oral metronidazole (400 mg twice daily for 7 days)
Number of subjects: 518
Study 34358521 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous suture technique
Number of subjects: 421
Study 34358521 — intervention group
Group type: COMPARATOR
Intervention: Interrupted suture technique
Number of subjects: 421
Study 35484106 — intervention group
Group type: EXPERIMENTAL
Intervention: HARPdoc (Hypoglycaemia Awareness Restoration Programme)
Number of subjects: 99
Study 35484106 — intervention group
Group type: COMPARATOR
Intervention: BGAT (Blood Glucose Awareness Training)
Number of subjects: 99
Study 35484106 — intervention group
Group type: EXPERIMENTAL
Intervention: HARPdoc
Number of subjects: 99
Study 33771685 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg/day
Number of subjects: 0
Study 33771685 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33100049 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure control (<120 mm Hg)
Number of subjects: 9361
Study 33100049 — intervention group
Group type: COMPARATOR
Intervention: Standard systolic blood pressure control (<140 mm Hg)
Number of subjects: 9361
Study 36111911 — intervention group
Group type: EXPERIMENTAL
Intervention: Radon baths (general baths at a temperature of 34‐36°C, duration 10‐15 minutes, every other day, No. 10)
Number of subjects: 40